PAHC
The stock hit the speed limit
Phibro Animal Health’s run has been wild enough to make even a calm long-term holder raise an eyebrow. The stock is trading around $53.88, basically parked near its 52-week high of $60.08 after ripping about 216% over the past year.
Then the insiders reached for the exit button
According to the filing, Director Jack Bendheim and BFI Co., LLC — a ten percent owner — sold shares between April 14 and April 16 for a total of $1,201,595. The sales happened at prices ranging from roughly $54.56 to $59.69, which is a very “thanks for the ride” kind of range.
BFI also converted 100,000 shares of Class B common stock into Class A common stock on April 16, which leaves it still sitting on a huge stake. So this isn’t a full-body collapse of confidence — more like a portfolio trim after a monster rally.
Why you should care
Insider sales can mean a bunch of things: diversification, tax planning, or just locking in gains after a huge move. But when a stock has already done a backflip off the trampoline, even small sales can make investors wonder if the easy money has already been made.
Big picture: Phibro’s fundamentals may still be strong, but the insiders seem perfectly happy to take some cash off the table while the stock is flying high.